about
Nanotechnology, nanotoxicology, and neurosciencePulmonary applications and toxicity of engineered nanoparticlesCarbon Nanomaterials Interfacing with Neurons: An In vivo PerspectiveSingle-wall carbon nanohorns inhibited activation of microglia induced by lipopolysaccharide through blocking of Sirt3Single-walled carbon nanohorn (SWNH) aggregates inhibited proliferation of human liver cell lines and promoted apoptosis, especially for hepatoma cell linesIn vitro controlled release of cisplatin from gold-carbon nanobottles via cleavable linkagesTargeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery.Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery.Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy.Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release.Influence of hyperthermia on efficacy and uptake of carbon nanohorn-cisplatin conjugatesSingle walled carbon nanohorns as photothermal cancer agents.In vitro and in vivo studies of single-walled carbon nanohorns with encapsulated metallofullerenes and exohedrally functionalized quantum dots.Nanocarriers for delivery of platinum anticancer drugs.Nanocontainers made of various materials with tunable shape and size.3D viability imaging of tumor phantoms treated with single-walled carbon nanohorns and photothermal therapy.Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy.Absorption and scattering properties of carbon nanohorn-based nanofluids for direct sunlight absorbers.Carbon nanohorn-based nanofluids: characterization of the spectral scattering albedo.Carbon nanotube nanoreservior for controlled release of anti-inflammatory dexamethasone.Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis.Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery.Radiolabeling, whole-body single photon emission computed tomography/computed tomography imaging, and pharmacokinetics of carbon nanohorns in mice.Imaging the distribution of individual platinum-based anticancer drug molecules attached to single-wall carbon nanotubesAdvancement in carbon nanotubes: basics, biomedical applications and toxicity.Review on the progress in synthesis and application of magnetic carbon nanocomposites.Cancer nanomedicine: from drug delivery to imaging.Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer.Platinum-based drugs: past, present and future.Facilitating Translational Nanomedicine via Predictive Safety Assessment.Osteoblasts response to nylon 6,6 blended with single-walled carbon nanohorn.Carbon Nanomaterials: Efficacy and Safety for Nanomedicine.Processing-structure-functional property relationship in organic-inorganic nanostructured scaffolds for bone-tissue engineering: the response of preosteoblasts.Programmable hydrogenation of graphene for novel nanocages.Advances in platinum chemotherapeutics.Polymer covalent functionalization of carbon nanohorns using bulk free radical polymerization.Quantification of whole body and excreted carbon nanohorns intravenously injected into mice.Anti-inflammatory Nanomedicine for Cardiovascular Disease.
P2860
Q24650444-B6DD6D9F-7767-4847-B205-74C245103F7EQ24650775-371D70D6-CA1E-42BA-8165-B59E86482072Q26745423-7EE11F4F-D18E-4184-8D66-2C85A3F59EDFQ28395706-B6EA5E22-DAE1-48F6-B618-C693E588F943Q28395783-7780EC67-4275-42C7-95B9-84F16B80ED44Q28397158-D530C400-ABF6-46A6-8923-5589BD41D46FQ30486828-46491A45-7609-4430-B667-E8A19158237EQ31035899-369631AA-8303-4516-B094-68EEB94D2073Q33371687-C81FD2DA-F2F2-46CD-A929-1DBFA4582476Q33528045-6EC3286B-7369-472F-AFC3-3D79B1E8AECCQ33622506-91608518-B0DC-4E5D-AD44-43AB42B36790Q33799550-1BF1D540-3066-43E0-9E81-877BD371B9A4Q34109226-7DCD6DB2-E905-4C91-99D8-2A287955ECE6Q34338695-768F5373-5E15-48F6-A115-C41DB2D93AC6Q34358437-B3C7935D-2798-4C3C-8C2A-B96F7A07D71CQ34777728-FB702D95-27B1-43DE-BBBF-FE418B6BA4CDQ34806920-414FA8AD-962F-41C7-9DCF-CD3B61A2FEBEQ34974112-BBCDCDF4-43EC-43EF-AB62-760D33B022C4Q35536850-7049D30D-4FF6-4612-A0C6-20A787272F00Q35799983-D76C4497-5587-4C38-BACA-A245A9B2F47BQ36069904-11BE09D1-195D-4AC7-AE82-D941E2AD44CBQ36125563-1C533838-9645-4C4A-B337-D06DE00BC41AQ36157633-8498F85C-27E2-4F65-B7BC-56FC6C55D69FQ37136162-9482E01B-17AE-47DA-9977-BDC857190BC6Q37464057-FAE8C3CC-560B-4721-8FA4-3992A7C81225Q37828625-6658331B-92F9-408B-B03D-BFD6E94C47F9Q37879561-7CD37408-F571-4652-ABAE-B320997468D2Q38172476-11CC9929-4E42-4CF4-AC85-C4E78471A036Q38286203-B3E3F6DA-FABD-491E-8729-B261D4E55261Q38633157-2815272B-2371-406B-B6F1-139E90308EE4Q38737115-C5FDDD62-B79C-45D6-B12F-AA1491DE931EQ39244552-9FD988C5-C7D1-4828-AB97-A093C90CBCC5Q39281574-C8B50090-7048-41C3-BDBD-CE08AC5A1B9AQ42145536-AA3F684D-A6B5-4FB9-9746-46F3E97C2BAEQ42833365-C8752693-05B5-436D-8814-5C3EB2566E1AQ42919411-702ABD4E-8AE4-482C-9D2A-F1CA1C0D5F61Q43038502-746455B2-CDBC-4A67-90C7-70EA928024E2Q43099931-E9284759-C0EF-4ED7-A06C-FE8B16F74BAAQ44185953-833A39D8-4841-46D9-8290-E23C2E9857EFQ47744781-45EC6F44-8EDC-4A2F-9B94-CE0F8E2F20D5
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Carbon nanohorns as anticancer drug carriers.
@ast
Carbon nanohorns as anticancer drug carriers.
@en
Carbon nanohorns as anticancer drug carriers.
@nl
type
label
Carbon nanohorns as anticancer drug carriers.
@ast
Carbon nanohorns as anticancer drug carriers.
@en
Carbon nanohorns as anticancer drug carriers.
@nl
prefLabel
Carbon nanohorns as anticancer drug carriers.
@ast
Carbon nanohorns as anticancer drug carriers.
@en
Carbon nanohorns as anticancer drug carriers.
@nl
P2093
P356
P1476
Carbon nanohorns as anticancer drug carriers.
@en
P2093
Alan Maigné
Kiyotaka Shiba
Kumiko Ajima
Masako Yudasaka
Tatsuya Murakami
P304
P356
10.1021/MP0500566
P407
P50
P577
2005-11-01T00:00:00Z